Innovation

Innovation powers the next generation of treatments and cures. See how PACH is working to protect and preserve cutting-edge medical innovation. 

The MINI Act

Innovation powers the next generation of treatments and cures. Mounting evidence shows that despite its best intentions, the passage of the Inflation Reduction Act has major unintended consequences, such as limiting treatment options and stifling innovation for cardiovascular patients. Medical innovation like genetically targeted technologies powers the next generation of treatments and cures. Treatments like GTTs use Nobel prize-winning science and can reduce patients’ number of pharmacy visits, simplify medication routines, and ultimately improve patients’ heart health management. 

Inflation Reduction Act

Patients and policymakers hope to see lower health care costs from the Inflation Reduction Act, but there are unintended consequences, such as limited treatment options and stifled innovation, that may affect cardiovascular patients.

Genetically Targeted Technologies

Genetically targeted technologies use Nobel prize-winning science and can reduce patients’ number of pharmacy visits, simplify medication routines, and ultimately improve patients’ heart health management. But only if patients can access them.